A dipeptidyl peptidase-4 inhibitor but not incretins suppresses abdominal aortic aneurysms in angiotensin II-infused apolipoprotein E-null mice

Journal of Atherosclerosis and Thrombosis

Volumn 23, Issue 4, 2016, Pages 441-454

  Kohashi, Kyoko ^a   Hiromura, Munenori ^a   Mori, Yusaku ^a   Terasaki, Michishige ^a   Watanabe, Takuya ^b   Kushima, Hideki ^a   Shinmura, Kyoko ^a   Tomoyasu, Masako ^a   Nagashima, Masaharu ^a,c   Hirano, Tsutomu ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c Hamano Nagashima Clinic   (Japan)

Author keywords

Abdominal aortic aneurysm; Angiotensin II; DPP 4 inhibitor; Incretin

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GELATINASE B; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; APOLIPOPROTEIN E; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; IL1B PROTEIN, MOUSE; INCRETIN; MMP9 PROTEIN, MOUSE;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FIBROSIS; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; AORTA; AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY;

ANGIOTENSIN II; ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; BLOOD PRESSURE; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; INCRETINS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84962468938     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.31997     Document Type: Article

References (51)

1. Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, Timaran CH, Upchurch GR Jr, Veith FJ: SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg, 2009; 50: 880-896
2. Verhoeven EL, Kapma MR, Groen H, Tielliu IF, Zeebregts CJ, Bekkema F, van den Dungen JJ: Mortality of ruptured abdominal aortic aneurysm treated with open or endovascular repair. J Vasc Surg, 2008; 48: 1396-1400
3. López-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW: Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol, 1997; 150: 993-1007
4. Shimizu K, Mitchell RN, Libby P: Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2006; 26: 987-994
5. Daugherty A, Manning MW, Cassis LA: Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol, 2001; 134: 865-870
6. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest, 2000; 105: 1605-1612
7. Thompson RW, Watanabe T, Ennis TL, Mao D, Pagano MB, Pham CT: Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci, 2006; 1085: 59-73
8. Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J, Miyazaki A, Hirano T: Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia, 2011; 54: 2649-2659
9. Terasaki M, Nagashima M, Nohtomi K, Kohashi K, Tomoyasu M, Sinmura K, Nogi Y, Katayama Y, Sato K, Itoh F, Watanabe T, Hirano T: Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin’s actions in nondiabetic and diabetic apolipoprotein E-null mice. PLoS One, 2013; 8: e70933
10. Terasaki M, Nagashima M, Watanabe T, Nohtomi K, Mori Y, Miyazaki A, Hirano T: Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice. Metabolism, 2012; 61: 974-977
11. Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A: Novel mechanisms of abdominal aortic aneurysms. Curr Atheroscler Rep, 2012; 14: 402-412
12. Daugherty A, Cassis LA: Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2004; 24: 429-434
13. Shiraishi Y, Watanabe T, Suguro T, Nagashima M, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M: Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. J Hypertens, 2008; 26: 1955-1965
14. Sueyoshi R, Woods Ignatoski KM, Okawada M, Hartmann B, Holst J, Teitelbaum DH: Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model. Am J Physiol Gastrointest Liver Physiol, 2014 15; 307: 410-419
15. Bostick B, Habibi J, Ma L, Aroor A, Rehmer N, Hayden MR, Sowers JR: Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity. Metabolism, 2014; 63: 1000-1011
16. Sparks AR, Johnson PL, Meyer MC: Imaging of abdominal aortic aneurysms. American family physician, 2002; 65: 1565-1570
17. Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, Viollet B, Xia L, Zhang Y, Zou MH: Activation of ampactivated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nature medicine, 2012; 18: 902-910
18. Hamblin M, Chang L, Zhang H, Yang K, Zhang J, Chen YE: Vascular smooth muscle cell peroxisome proliferatoractivated receptor-gamma deletion promotes abdominal aortic aneurysms. J Vasc Surg, 2010; 52: 984-993
19. Bao W, Morimoto K, Hasegawa T, Sasaki N, Yamashita T, Hirata K, Okita Y, Okada K: Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats. J Vasc Surg, 2014; 59: 1098-1108
20. Lu HY, Huang CY, Shih CM, Chang WH, Tsai CS, Lin FY, Shih CC: Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice. PLoS One, 2015; 10: e0121077
21. Manning MW, Cassis LA, Daugherty A: Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 2003; 23: 483-488
22. Montrose-Rafizadeh C, Yang H, Rodgers BD, Beday A, Pritchette LA, Eng J: High potency antagonists of the pancreatic glucagon-like peptide-1 receptor. J Biol Chem, 1997; 272: 21201-21206
23. Patterson JT, Ottaway N, Gelfanov VM, Smiley DL, Perez-Tilve D, Pfluger PT, Tschöp MH, Dimarchi RD: A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1. ACS Chem Biol, 2011; 6: 135-145
24. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE III.: Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology, 1993; 133: 57-62
25. Ban K, Kim H, Cho J, Diamandis E, Backx PH, Drucker DJ, Husain M: Glp-1(9-36) protects cardiomyocytes and endothelial cells from ischemia-reperfusion injury via cytoprotective pathways independent of the glp-1 receptor. Endocrinology, 2010; 151: 1520-1531
26. Dinarello CA: A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol, 2011; 41: 1203-1217
27. Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD: Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation, 1994; 90: II224-II227
28. Pearce WH, Sweis I, Yao JS, McCarthy WJ, Koch AE: Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. J Vasc Surg, 1992; 16: 784-789
29. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjälä H, Airaksinen J, Leinonen M, Saikku P, Juvonen T: Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol, 1997; 17: 2843-2847
30. Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, Owens GK, Upchurch GR Jr, Ailawadi G: Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol, 2013; 33: 294-304
31. Ta NN, Schuyler CA, Li Y, Lopes-Virella MF, Huang Y: DPP-4 (CD 26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol, 2011; 58: 157-166
32. Treska V, Kocova J, Boudova L, Neprasova P, Topolcan O, Pecen L, Tonar Z: Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cytokines Cell Mol Ther, 2002; 7: 91-97
33. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT: Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest, 2002; 110: 625-632
34. Murphy G: Tissue inhibitors of metalloproteinases. Genome Biol, 2011; 12: 233
35. Johnson JL, Baker AH, Oka K, Chan L, Newby AC, Jackson CL, George SJ: Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation, 2006; 113: 2435-2444
36. Dunn SL, Wilkinson JM, Crawford A, Le Maitre CL, Bunning RA: Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes. Osteoarthritis Cartilage, 2014; 22: 133-144
37. Rouet-Benzineb P, Gontero B, Dreyfus P, Lafuma C: Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J Mol Cell Cardiol, 2000; 32: 1767-1778
38. Ikeda T, Kumagai E, Iwata S, Yamakawa A: Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes. PLoS One, 2013; 8: e66520
39. Zhang Y, Naggar JC, Welzig CM, Beasley D, Moulton KS, Park HJ, Galper JB: Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol, 2009; 29: 1764-1771
40. Saraff K, Babamusta F, Cassis LA, Daugherty A: Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 2003; 23: 1621-1626
41. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA Jr, Willerson JT, Ferrans VJ: Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan’s syndrome. Circulation, 1998; 98: 331-337
42. Thieszen SL, Dalton M, Gadson PF, Patterson E, Rosenquist TH: Embryonic lineage of vascular smooth muscle cells determines responses to collagen matrices and integrin receptor expression. Exp Cell Res, 1996; 227: 135-145
43. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A: Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol, 2011; 179: 1542-1548
44. Dobrin PB, Mrkvicka R: Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg, 1994; 2: 484-488
45. Satta J, Juvonen T, Haukipuro K, Juvonen M, Kairaluoma MI: Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type Ⅲ procollagen in peripheral and aortal blood samples. J Vasc Surg, 1995; 22: 155-160
46. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Yoshimura K, Aoki H, Tsutsui H, Noda T, Sagara J, Taniguchi S, Takahashi M: Inflammasome Acti-vation by Mitochondrial Oxidative Stress in Macrophages Leads to the Development of Angiotensin II-Induced Aortic Aneurysm. Arterioscler Thromb Vasc Biol, 2015; 35: 127-136
47. Campbell JE, J DD: Pharmacology physiology and mechanisms of incretin hormone action. Cell metabolism, 2013; 17: 819-837
48. Ussher JR, Drucker DJ: Cardiovascular biology of the incretin system. Endocr Rev, 2012; 33: 187-215
49. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood, 2004; 104: 3472-3482
50. Olive M, Mellad JA, Beltran LE, Ma M, Cimato T, Noguchi AC, San H, Childs R, Kovacic JC, Boehm M: p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/ CXCR4 axis in mice. J Clin Invest, 2008; 118: 2050-2061
51. Hoh BL, Hosaka K, Downes DP, Nowicki KW, Wilmer EN, Velat GJ, Scott EW: Stromal cell-derived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls. J Neurosurg, 2014; 120: 73-86